Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -266.96 | -17.42 |
PEG Ratio (TTM) | 1.56 | -5.52 |
P/S Ratio (TTM) | N/A | 38.74 |
P/B Ratio (TTM) | 1.58 | 5.80 |
P/FCF Ratio (TTM) | -199.55 | -149.29 |
Price to 5YR AVG Earnings Ratio | N/A | -33.90 |
Price to 5YR AVG FCF Ratio | N/A | -1.08 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.47% | 287.17% |
ROE (TTM) | -0.43% | -4,217.47% |
Net Profit Margin (TTM) | N/A | -1,033.79% |
ROIC 5YR AVG | N/A | -16.17% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -58.08% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -32.61% | N/A | N/A |
Cash Flow | -373.69% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.00 | 4.93 |
Quick Ratio (TTM) | 0.00 | 4.91 |
D/E Ratio (TTM) | 0.01 | 1.29 |
Interest Coverage (TTM) | -3.01 | -11.10 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 3.38 | 20.95 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 889.12% |